60
Participants
Start Date
June 4, 2020
Primary Completion Date
December 31, 2030
Study Completion Date
December 31, 2030
Immunoglobulin
Randomization 1:1 to the same total dose of either SCIG or IVIG for 26 weeks of stable dose + 60 weeks of redcution.
NOT_YET_RECRUITING
Department of Neurology, Rigshospitalet, Copenhagen University Hospital, Copenhagen
NOT_YET_RECRUITING
Department of Neurology, Odense University Hospital, Odense
RECRUITING
Department of Neurology, Aarhus University Hospital, Aarhus C
NOT_YET_RECRUITING
Department of Neurology, Aalborg University Hospital, Aalborg
Rigshospitalet, Denmark
OTHER
Aarhus University Hospital
OTHER
Odense University Hospital
OTHER
Aalborg University Hospital
OTHER
University of Aarhus
OTHER